Investigateur(trice) de site BRAVO – CDD 6 mois

About the role

The BRAVO study is a prospective evaluation supporting the deployment of the ERVEBO vaccine to frontline health workers during the Bundibugyo Ebola virus outbreak in the Democratic Republic of the Congo. The Site Investigator will be based in the affected regions (Ituri or North‑Kivu) and will work closely with Médecins Sans Frontières (MSF) and Epicentre teams, under the supervision of the Epicentre Research Director and the MSF project medical referent.

Key responsibilities

• Recruit, train and coordinate a multidisciplinary study team including clinicians, nurses, data monitors, health promoters, data managers, data entry staff, logistics and HR personnel.
• Ensure strict compliance with the study protocol and Good Clinical Practice standards across all study sites.
• Oversee data collection, monitoring and reporting activities, guaranteeing data quality and integrity.
• Liaise with MSF operational centres and the Principal Investigator to align study activities with the overall epidemic response.
• Facilitate the safe administration of the ERVEBO vaccine and support the evaluation of additional vaccine strategies.

Required profile

• Proven experience in clinical research or epidemiological studies, preferably in infectious‑disease settings.
• Ability to manage and motivate a field‑based research team.
• Fluency in French and working knowledge of English.
• Willingness to work on‑site in remote areas of the DRC under challenging conditions.
• Strong organisational skills and ability to work under hierarchical and functional supervision.

Required skills

• Good Clinical Practice (GCP) knowledge.
• Clinical trial management.
• Data collection and monitoring procedures.